Philadelphia Chromosome - 26 Studies Found
Completed |
: Rollover Study of BMS-354825 in Patients With CML and Ph+ALL :
|
Withdrawn |
: Study of Dasatinib in Imatinib Resistant or Intolerant Subjects With Chronic or Advanced Phase CML or Philadelphia Chromosome Positive ALL :
: 2006-07-06 : Drug: Dasatinib |
Withdrawn |
: Nilotinib and Combination Chemotherapy in Treating Patients With Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia or Blastic Phase Chronic Myelogenous Leukemia :
: |
Completed |
: Efficacy Study of Imatinib Mesylate to Treat Philadelphia-Positive Acute Lymphocytic Leukemia : Philadelphia Chromosome Positive Acute Lymphocytic Leukemia : 2005-09-09 : Drug: Imatinib Mesylate Other Names:
|
Completed |
: A Phase II Study of Flumatinib Versus Imatinib to Treat Philadelphia Chromosome Positive Chronic Myelogenous Leukemia : Myelogenous Leukemia, Chronic : 2012-01-01 :
|
RECRUITING |
: Chemotherapy (DA-EPOCH+/-R) and Targeted Therapy (Tafasitamab) for the Treatment of Newly-Diagnosed Philadelphia Chromosome Negative B Acute Lymphoblastic Leukemia : B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative : 2024-05-14 : Ancillary studies |